With the multitude of complex issues associated with clinical trials in diabetes, it is clear that there is a necessity to streamline these issues into a process that will improve drug development in terms of approval and commercialization and address the various aspects of drug and device development and the way to enhance them.Our world renowned faculty will tackle these issues head on through a comprehensive scientific program which will focus on four key areas; Design the Best Study Improve Regulatory Process; Better Understanding of How to Collaborate with Regulatory Authorities Involvement of Digital Medicine Power Post-Marketing Surveillance.